Clinical Trial Update: Pharmacokinetic Profile of BIA 6-512 in Healthy Elderly Subjects Versus Healthy Young Subjects [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetic study compares exposure of the drug BIA 6-512 between healthy elderly and healthy young subjects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• BIA 6-512

Snippet

Sponsor: Bial - Portela C S.A. | Conditions: Parkinson Disease | Phase 1 | Status: COMPLETED